Interleukins as Mediators of the Tumor Cell—Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis
Patients with advanced breast cancer are at high risk of developing bone metastasis. Despite treatment advances for primary breast cancer, metastatic bone disease remains incurable with a low relative survival. Hence, new therapeutic approaches are required to improve survival and treatment outcome...
Main Authors: | Marie-Therese Haider, Nicole Ridlmaier, Daniel J. Smit, Hanna Taipaleenmäki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/6/2898 |
Similar Items
-
The osteoblast in regulation of tumor cell dormancy and bone metastasis
by: Jennifer Zarrer, et al.
Published: (2024-04-01) -
MicroRNAs: Emerging Regulators of Metastatic Bone Disease in Breast Cancer
by: Marie-Therese Haider, et al.
Published: (2022-01-01) -
Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis
by: Rongchen Dai, et al.
Published: (2022-10-01) -
The role of the bone microenvironment in regulating myeloma residual disease and treatment
by: Terry G. Dadzie, et al.
Published: (2022-08-01) -
Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth
by: Lauren M. Kreps, et al.
Published: (2021-03-01)